– FRANCE, Paris – Abivax SA (EPA: ABVX / Nasdaq: ABVX), a biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases, announced the appointment of Dr.…
– USA, FL – NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS), a clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease, announced the appointment of Adele Gulfo to its Board as an independent director.…
– DENMARK, Copenhagen – Orbis Medicines, a leader in oral macrocycle drug discovery, announced the appointment of Dr.…
– USA. WA – AltPep Corporation, a privately held biotechnology company developing early disease-modifying treatments and detection tools for amyloid diseases, announced the appointment of Dr.…
– USA, NJ – Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announced the appointment of Evelyn D’An to its Board as an Independent Director and Chair of the Audit Committee, effective February 5, 2025.…